全文获取类型
收费全文 | 3162篇 |
免费 | 177篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 107篇 |
妇产科学 | 33篇 |
基础医学 | 263篇 |
口腔科学 | 100篇 |
临床医学 | 236篇 |
内科学 | 784篇 |
皮肤病学 | 43篇 |
神经病学 | 150篇 |
特种医学 | 151篇 |
外科学 | 662篇 |
综合类 | 79篇 |
一般理论 | 1篇 |
预防医学 | 258篇 |
眼科学 | 57篇 |
药学 | 213篇 |
中国医学 | 16篇 |
肿瘤学 | 180篇 |
出版年
2023年 | 29篇 |
2022年 | 36篇 |
2021年 | 108篇 |
2020年 | 58篇 |
2019年 | 77篇 |
2018年 | 101篇 |
2017年 | 59篇 |
2016年 | 67篇 |
2015年 | 60篇 |
2014年 | 132篇 |
2013年 | 153篇 |
2012年 | 181篇 |
2011年 | 230篇 |
2010年 | 134篇 |
2009年 | 130篇 |
2008年 | 162篇 |
2007年 | 173篇 |
2006年 | 165篇 |
2005年 | 163篇 |
2004年 | 140篇 |
2003年 | 153篇 |
2002年 | 150篇 |
2001年 | 64篇 |
2000年 | 68篇 |
1999年 | 50篇 |
1998年 | 20篇 |
1997年 | 10篇 |
1996年 | 19篇 |
1995年 | 18篇 |
1994年 | 17篇 |
1993年 | 14篇 |
1992年 | 33篇 |
1991年 | 36篇 |
1990年 | 35篇 |
1989年 | 27篇 |
1988年 | 31篇 |
1987年 | 35篇 |
1986年 | 26篇 |
1985年 | 27篇 |
1984年 | 14篇 |
1983年 | 10篇 |
1981年 | 8篇 |
1979年 | 15篇 |
1978年 | 13篇 |
1973年 | 11篇 |
1970年 | 9篇 |
1969年 | 13篇 |
1968年 | 8篇 |
1967年 | 7篇 |
1966年 | 9篇 |
排序方式: 共有3357条查询结果,搜索用时 250 毫秒
41.
Atin Jaiswal Naiman Deepak Kachchhapt Rupak Chaterjee Yashwant Singh Tanwar Masood Habib Satya Prakash Singh 《中华创伤杂志(英文版)》2013,16(6):379-381
Fractures of the proximal humerus are uncommon in young patients.Although bilateral fracture of proximal humerus itself is rare,association with epilepsy and electrocution is frequent.Only one case of traumatic bilateral proximal humerus fracture has been reported in the literature.We report a rare case of bilateral traumatic displaced proximal humerus fractures in a 40 years old male patient,which was treated by means of open reduction and internal fixation with proximal humerus locked pates on both sides and obtained a good functional outcome. 相似文献
42.
43.
Human and equine rabies immunoglobulins are currently available for passive immunization against rabies. However, these are hampered by the limited supply and some drawbacks. Advances in antibody engineering have led to overcome issues of clinical applications and to improve the protective efficacy. In the present study, we report the generation of a trivalent single-chain Fv (scFv50AD1-Fd), that recognizes the rabies virus glycoprotein, genetically fused to the trimerization domain of the bacteriophage T4 fibritin, termed ‘foldon’ (Fd). scFv50AD1-Fd was expressed as soluble recombinant protein in bacterial periplasmic space and purified through affinity chromatography. The molecular integrity and stability were analyzed by polyacrylamide gradient-gel electrophoresis, size-exclusion chromatography and incubation in human sera. The antigen-binding properties of the trimeric scFv were analyzed by direct and competitive-ELISA. Its apparent affinity constant was estimated at 1.4 ± 0.25 × 109 M−1 and was 75-fold higher than its monovalent scFv (1.9 ± 0.68 × 107 M−1). The scFv50AD1-Fd neutralized rabies virus in a standard in vitro and in vivo neutralization assay. We showed a high neutralization activity up to 75-fold compared with monovalent format and the WHO standard serum. The gain in avidity resulting from multivalency along with an improved biological activity makes the trivalent scFv50AD1-Fd construct an important reagent for rabies protection. The antibody engineering approach presented here may serve as a strategy for designing a new generation of anti-rabies for passive immunotherapy. 相似文献
44.
45.
Blastic plasmacytoid dendritic cell neoplasm: the first report of two cases treated by 5‐Azacytidine
Kamel Laribi Nathalie Denizon Habib Ghnaya Mustapha Atlassi Anne Besançon Fabienne Pineau‐Vincent Philippe Gaulard Tony Petrella 《European journal of haematology》2014,93(1):81-85
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy which was first included as an independent cutaneous lymphoma in the 2008 World Health Organisation (WHO) classification (1). BPDCN usually has an extremely poor prognosis, with quick relapses after chemotherapy (2; 3). Here, we report two cases of patients diagnosed in 2011 with BPDCN and myelodysplasia, and who were treated for the first time with 5‐azacytidine (5‐Aza); a drug approved by the Food and Drug Administration (FDA) and mainly used in the treatment of myelodysplastic syndrome (Kaminskas E, et al. 2005 Clin Cancer Res, 11, 3604–8). The first case was an 81‐year‐old man who presented with unusual CD10+, CD56‐ immunohistochemistry and 45X, ‐Y abnormality using fluorescent in situ hybridization (FISH) analysis. The second case was a 78‐year‐old woman who manifested monosomy 13 and chromosome instability due to D13S319 locus deletion in 13q14 as determined by FISH. Both patients showed excellent responses of their skin lesions after one cycle of chemotherapy, and their hematological disease was stabilized; however, pulmonary sepsis set in, followed by neutropenia after the fourth and the fifth cycle of treatment, that is, eight and 9 months postdiagnosis, respectively, leading to patient death. 相似文献
46.
Assessment of myocardial partition coefficient of gadolinium (λ) in dilated cardiomyopathy and its impact on segmental and global systolic function
下载免费PDF全文
![点击此处可从《Journal of magnetic resonance imaging : JMRI》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Alexis Jacquier MD PhD Alexandros Kallifatidis MD Nicolas Guibert MD Roch Giorgi MD PhD Claire Falque MD Franck Thuny MD PhD Pierre Croisille MD PhD Patrick Clarysse PhD Boris Maurel MD Antonin Flavian MD Jean‐Yves Gaubert MD Guy Moulin MD Gilbert Habib MD 《Journal of magnetic resonance imaging : JMRI》2014,40(6):1336-1341
47.
Sharmistha Chakraborty Li Li Hao Tang Yang Xie Vineshkumar Thidil Puliyappadamba Jack Raisanen Sandeep Burma David A Boothman Brent Cochran Julian Wu Amyn A Habib 《Neoplasia (New York, N.Y.)》2013,15(8):888-897
Tumor necrosis factor receptor 1 (TNFR1)-associated death domain protein (TRADD) is an important adaptor in TNFR1 signaling and has an essential role in nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation and survival signaling. Increased expression of TRADD is sufficient to activate NF-κB. Recent studies have highlighted the importance of NF-κB activation as a key pathogenic mechanism in glioblastoma multiforme (GBM), the most common primary malignant brain tumor in adults.We examined the expression of TRADD by immunohistochemistry (IHC) and find that TRADD is commonly expressed at high levels in GBM and is detected in both cytoplasmic and nuclear distribution. Cytoplasmic IHC TRADD scoring is significantly associated with worse progression-free survival (PFS) both in univariate and multivariate analysis but is not associated with overall survival (n = 43 GBMs). PFS is a marker for responsiveness to treatment. We propose that TRADD-mediated NF-κB activation confers chemoresistance and thus a worse PFS in GBM. Consistent with the effect on PFS, silencing TRADD in glioma cells results in decreased NF-κB activity, decreased proliferation of cells, and increased sensitivity to temozolomide. TRADD expression is common in glioma-initiating cells. Importantly, silencing TRADD in GBM-initiating stem cell cultures results in decreased viability of stem cells, suggesting that TRADD may be required for maintenance of GBM stem cell populations. Thus, our study suggests that increased expression of cytoplasmic TRADD is both an important biomarker and a key driver of NF-κB activation in GBM and supports an oncogenic role for TRADD in GBM. 相似文献
48.
49.
50.
Boukerche H Su ZZ Prévot C Sarkar D Fisher PB 《Proceedings of the National Academy of Sciences of the United States of America》2008,105(41):15914-15919
The scaffold PDZ-domain containing protein mda-9/syntenin functions as a positive regulator of cancer cell progression in human melanoma and other tumors. mda-9/Syntenin regulates cell motility and invasion by altering defined biochemical and signaling pathways, including focal adhesion kinase (FAK), p38 mitogen-activated protein kinase (MAPK) and NF-κB, but precisely how mda-9/syntenin organizes these multiprotein signaling complexes is not well understood. Using a clinically relevant human melanoma model, we demonstrate that mda-9/syntenin physically interacts with c-Src and this communication correlates with an increase in FAK/c-Src complex formation and c-Src activation. Inhibiting mda-9/syntenin, using an adenovirus expressing antisense mda-9/syntenin or addition of c-Src siRNA, suppresses melanoma cell migration, anchorage-independent growth, and spontaneous tumor cell dissemination in vivo in a human melanoma animal metastasis model. These data are compatible with a model wherein interaction of MDA-9/syntenin with c-Src promotes the formation of an active FAK/c-Src signaling complex, leading to enhanced tumor cell invasion and metastatic spread. These provocative findings highlight mda-9/syntenin and its interacting partners as promising therapeutic targets for intervention of metastasis. 相似文献